Histochem Cell Biol (2010) 134:205–213 Open Access This article is distributed under the terms of the Crea- tive Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. References Bonifacino JS (2004) Insights into the biogenesis of lysosome-related organelles from the study of Hermanksy-Pudlak syndrome. Ann NY Acad Sci 1038:103–114 Borzone G, Moreno R, Urrea R, Meneses M, Oyarzun M, Lisboa C (2001) Bleomycin-induced chronic lung damage does not resem- ble human idiopathic pulmonary Wbrosis. Am J Respir Crit Care Med 163:1648–1653 Chen Y, Wang X, Weng D, Tao S, Lv L, Chen J (2009) A TSP-1 func- tional fragment inhibits activation of latent transforming growth factor-beta1 derived from rat alveolar macrophage after bleomy- cin treatment. Exp Toxicol Pathol 61(1):67–73 Chi EY, Prueitt JL, LagunoV D (1975) Abnormal lamellar bodies in type II pneumocytes and increased lung surface active material in the beige mouse. J Histochem Cytochem 23:863–869 Feng L, Seymour AB, Jiang S, To A, Peden AA, Novak EK, Zhen L, Rusiniak ME, Eicher EM, Robinson MS, Gorin MB, Swank RT (1999) The beta-3A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and night blindness. Hum Mol Genet 8:323–330 Feng L, Novak EK, Hartnell LM, Bonifacino JS, Collinson LM, Swank RT (2002) The Hermansky-Pudlak syndrome (HPS1) and HPS2 genes independently contribute to the production and function of platelet dense granules, melanosomes, and lysosomes. Blood 99:1651–1658 Gu L, Zhu YJ, Yang X, Guo ZJ, Xu WB, Tian XL (2007) EVect of TGF-beta/Smad signaling pathway on lung myoWbroblast diVer- entiation. Acta Pharmacol Sin 28(3):382–391 Guttentag SH, Akhtar A, Tao J, Atochina E, Rusiniak ME, Swank RT, Bates SR (2005) Defective surfactant secretion in a mouse model of Hermansky-Pudlak syndrome. Am J Respir Cell Mol Biol 33:14–21 HoVman AM, Shifren A, Mazan MR, Gruntman AM, Lascola KM, Nolen-Walston RD, Kim CF, Tsai L, Pierce RA, Mecham RP, Ingenito EP (2010) Matrix modulation of compensatory lung regrowth and progenitor cell proliferation in mice. Am J Physiol Lung Cell Mol Physiol 298(2):L158–L168 Ikegami M, Whitsett JA, Martis PC, Weaver TE (2005) Reversibility of lung inXammation caused by SP-B deWciency. Am J Physiol Lung Cell Mol Physiol 289:L962–L970 Intone WJ, Westbroek W, Golas GA and Adams D (2009) Chediak- Higashi syndrome. Gene reviews: http://www.ncbi.nlm.nih.gov/ bookshelf/br.fcgi?book=gene&part=chediak-higashi Kim JH, Jang YS, Eom KS, Hwang YI, Kang HR, Jang SH, Kim CH, Park YB, Lee MG, Hyun IG, Jung KS, Kim DG (2007) 213 Transforming growth factor beta1 induces epithelial-to-mesen- chymal transition of A549 cells. J Korean Med Sci 22:898–904 Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML, Frank JA, Brumwell AN, Wheeler SE, Kreidberg JA, Chapman HA (2009) Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myoWbroblast formation and pulmo- nary Wbrosis. J Clin Invest 119:213–224 KönigshoV M, Kramer M, Balsara N, Wilhelm J, Amarie OV, Jahn A, Rose F, Fink L, Seeger W, Schaefer L, Günther A, Eickelberg O (2009) WNT1-inducible signaling protein-1 mediates pulmonary Wbrosis in mice and is upregulated in humans with idiopathic pulmonary Wbrosis. J Clin Invest 119:772–787 Lazo JS (1981) Angiotensin converting enzyme activity in mice after subacute bleomycin administration. Toxicol Appl Pharmacol 59:395–404 Li W, Rusiniak ME, Chintala S, Gautam R, Novak EK, Swank RT (2004) Murine Hermansky-Pudlak syndrome genes: regulators of lysosome-related organelles. Bioessays 26:616–628 Liu Y (2004) Epithelial to mesenchymal transition in renal Wbrogene- sis: pathologic signiWcance, molecular mechanism, and therapeu- tic intervention. J Am Soc Nephrol 15:1–12 Lyerla TA, Rusiniak ME, Borchers M, Jahreis G, Tan J, Ohtake P, Novak EK, Swank RT (2003) Aberrant lung structure, composi- tion, and function in a murine model of Hermansky-Pudlak syn- drome. Am J Physiol Lung Cell Mol Physiol 285:L643–L653 Nakatani Y, Nakamura N, Sano J, Inayama Y, Kawano N, Yamanaka S, Miyagi Y, Nagashima Y, Ohbayashi C, Mizushima M, Manabe T, Kuroda M, Yokoi T, Matsubara O (2000) Interstitial pneumo- nia in Hermansky-Pudlak syndrome: signiWcance of Xorid foamy swelling/degeneration (giant lamellar body degeneration) of type- 2 pneumocytes. Virchows Arch 437:304–313 Nishimura Y, Nishiike-Wada T, Wada Y, Miura Y, Otsuki T, Iguchi H (2007) Long-lasting production of TGF-beta1 by alveolar macro- phages exposed to low doses of asbestos without apoptosis. Int J Immunopathol Pharmacol. 20:661–671 Prueitt JL, Chi EY, LagunoV D (1978) Pulmonary surface-active materials in the Chediak-Higashi syndrome. J Lipid Res 19:410–415 Tang X, Yamanaka S, Miyagi Y, Nagashima Y, Nakatani Y (2005) Lung pathology of pale ear mouse (model of Hermansky-Pudlak syndrome 1) and beige mouse (model of Chediak-Higashi syn- drome): Severity of giant lamellar body degeneration of type II pneumocytes correlates with interstitial inXammation. Pathol Intern 55:137–143 Thurlbeck WM (1967) Measurement of pulmonary emphysema. Am Rev Resp Dis 95:752–764 Wei ML (2006) Hermansky-Pudlak syndrome: a disease of protein traYcking and organelle function. Pig Cell Res 19:19–42 Yamada M, Kuwano K, Maeyama T, Hamada N, Yoshimi M, Nakanishi Y, Kasper M (2008) Dual-immunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary Wbrosis. Histochem Cell Biol 129:453–462 123